Familial benign hypercalcaemia. Study of a large family. 1983

F H Menko, and O L Bijvoet, and J L Fronen, and L M Sandler, and S Adami, and J L O'Riordan, and W Schopman, and G Heynen

Twenty-seven hypercalcaemic subjects were identified in three generations of a family. There were no clinical complications of chronic hypercalcaemia, but five had had parathyroid surgery which was unsuccessful in four. Twenty of the twenty-seven subjects were compared with twenty-four normocalcaemic controls from the same family and the findings were also compared with those from forty patients with surgically proven primary hyperparathyroidism. The relation between the serum and urinary calcium levels was studied by means of an oral calcium loading test. The ratio of calcium clearance to creatinine clearance was normal in this family (but elevated in the patients with primary hyperparathyroidism) and the concentration of parathyroid hormone was normal, as was the total urinary excretion of cyclic AMP. Thus, there was no evidence of either suppressed or increased parathyroid activity in this familial condition. Basal urinary calcium excretion was normal under steady-state conditions indicating that the hypercalcaemia could not be attributed to either increased bone resorption or increased calcium absorption from the gut. In accordance with this, the serum levels of 1,25-dihydroxycholecalciferol were normal. The hypercalcaemia in this condition can be accounted for in full by an increase in renal tubular reabsorption of calcium, and thus differs from that of primary hyperparathyroidism in which there is increased production of calcium from gut and/or bone as well as an increase in renal tubular reabsorption of calcium. Although the serum phosphate and renal tubular reabsorption of phosphate were both low in patients with familial benign hypercalcaemia, they were not as low as in patients with the same degree of hypercalcaemia due to primary hyperparathyroidism. The changes in phosphate transport in familial benign hypercalcaemia could be explained as a secondary effect of the increased filtered load of calcium in the kidney. The tendency towards hypermagnesaemia in our patients, which contrasts with a tendency towards hypomagnesaemia in primary hyperparathyroidism, could also be explained as a secondary effect of the abnormality of renal tubular reabsorption of calcium. Increased renal tubular calcium reabsorption and persistent normal functioning of the parathyroid glands in the face of hypercalcaemia remain the sole definite abnormalities of the syndrome.

UI MeSH Term Description Entries
D008274 Magnesium A metallic element that has the atomic symbol Mg, atomic number 12, and atomic weight 24.31. It is important for the activity of many enzymes, especially those involved in OXIDATIVE PHOSPHORYLATION.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010281 Parathyroid Hormone A polypeptide hormone (84 amino acid residues) secreted by the PARATHYROID GLANDS which performs the essential role of maintaining intracellular CALCIUM levels in the body. Parathyroid hormone increases intracellular calcium by promoting the release of CALCIUM from BONE, increases the intestinal absorption of calcium, increases the renal tubular reabsorption of calcium, and increases the renal excretion of phosphates. Natpara,PTH (1-84),PTH(1-34),Parathormone,Parathyrin,Parathyroid Hormone (1-34),Parathyroid Hormone (1-84),Parathyroid Hormone Peptide (1-34),Hormone, Parathyroid
D010375 Pedigree The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition. Family Tree,Genealogical Tree,Genealogic Tree,Genetic Identity,Identity, Genetic,Family Trees,Genealogic Trees,Genealogical Trees,Genetic Identities,Identities, Genetic,Tree, Family,Tree, Genealogic,Tree, Genealogical,Trees, Family,Trees, Genealogic,Trees, Genealogical
D010710 Phosphates Inorganic salts of phosphoric acid. Inorganic Phosphate,Phosphates, Inorganic,Inorganic Phosphates,Orthophosphate,Phosphate,Phosphate, Inorganic
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children

Related Publications

F H Menko, and O L Bijvoet, and J L Fronen, and L M Sandler, and S Adami, and J L O'Riordan, and W Schopman, and G Heynen
October 1987, Postgraduate medical journal,
F H Menko, and O L Bijvoet, and J L Fronen, and L M Sandler, and S Adami, and J L O'Riordan, and W Schopman, and G Heynen
July 1981, Lancet (London, England),
F H Menko, and O L Bijvoet, and J L Fronen, and L M Sandler, and S Adami, and J L O'Riordan, and W Schopman, and G Heynen
February 2011, Scottish medical journal,
F H Menko, and O L Bijvoet, and J L Fronen, and L M Sandler, and S Adami, and J L O'Riordan, and W Schopman, and G Heynen
September 2002, Clinical genetics,
F H Menko, and O L Bijvoet, and J L Fronen, and L M Sandler, and S Adami, and J L O'Riordan, and W Schopman, and G Heynen
January 1993, Annals of clinical biochemistry,
F H Menko, and O L Bijvoet, and J L Fronen, and L M Sandler, and S Adami, and J L O'Riordan, and W Schopman, and G Heynen
August 1985, Clinical endocrinology,
F H Menko, and O L Bijvoet, and J L Fronen, and L M Sandler, and S Adami, and J L O'Riordan, and W Schopman, and G Heynen
September 1994, The Netherlands journal of medicine,
F H Menko, and O L Bijvoet, and J L Fronen, and L M Sandler, and S Adami, and J L O'Riordan, and W Schopman, and G Heynen
January 1958, Bulletins et memoires de la Societe medicale des hopitaux de Paris,
F H Menko, and O L Bijvoet, and J L Fronen, and L M Sandler, and S Adami, and J L O'Riordan, and W Schopman, and G Heynen
December 1984, European journal of clinical investigation,
F H Menko, and O L Bijvoet, and J L Fronen, and L M Sandler, and S Adami, and J L O'Riordan, and W Schopman, and G Heynen
March 1989, Journal of internal medicine,
Copied contents to your clipboard!